We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HROW icon
1201
Harrow
HROW
$1.44B
$2K ﹤0.01%
+110
New +$1.31K
ITOS
1202
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
KNSA icon
1203
Kiniksa Pharmaceuticals
KNSA
$6.23B
$2K ﹤0.01%
139
+79
+132% +$1.15K
KZR
1204
DELISTED
Kezar Life Sciences
KZR
$2K ﹤0.01%
28
+13
+87% +$964
MRSN
1205
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
16
+6
+60% +$1.01K
MXCT icon
1206
MaxCyte
MXCT
$109M
$2K ﹤0.01%
293
NRIX icon
1207
Nurix Therapeutics
NRIX
$2.45B
$2K ﹤0.01%
152
PHAT icon
1208
Phathom Pharmaceuticals
PHAT
$928M
$2K ﹤0.01%
167
+75
+82% +$773
PTGX icon
1209
Protagonist Therapeutics
PTGX
$8.54B
$2K ﹤0.01%
163
RAPT
1210
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
RPTX
1211
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
127
SGMO
1212
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2K ﹤0.01%
498
SIGA icon
1213
SIGA Technologies
SIGA
$239M
$2K ﹤0.01%
270
SRRK icon
1214
Scholar Rock
SRRK
$5.88B
$2K ﹤0.01%
208
+90
+76% +$722
TARS icon
1215
Tarsus Pharmaceuticals
TARS
$2.55B
$2K ﹤0.01%
+107
New +$1.77K
TBPH icon
1216
Theravance Biopharma
TBPH
$874M
$2K ﹤0.01%
215
TERN
1217
DELISTED
Terns Pharmaceuticals
TERN
$2K ﹤0.01%
+151
New +$1K
WVE icon
1218
Wave Life Sciences
WVE
$1.12B
$2K ﹤0.01%
349
+250
+253% +$1.15K
KLRS
1219
Kalaris Therapeutics
KLRS
$80.4M
$2K ﹤0.01%
16
+6
+60% +$1.02K
TVRD
1220
Tvardi Therapeutics
TVRD
$20.2M
$2K ﹤0.01%
5
PSTX
1221
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2K ﹤0.01%
346
+230
+198% +$1.05K
CBAY
1222
DELISTED
Cymabay Therapeutics
CBAY
$2K ﹤0.01%
341
+189
+124% +$718
ICPT
1223
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
167
+105
+169% +$1.49K
CINC
1224
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$2K ﹤0.01%
+176
New +$4.19K
ABOS icon
1225
Acumen Pharmaceuticals
ABOS
$152M
$1K ﹤0.01%
+165
New +$1.11K

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.